Serial echocardiographic left ventricular ejection fraction measurements: A tool for detecting thalassemia major patients at risk of cardiac death

Blood Cells, Molecules, and Diseases

Volumn 50, Issue 4, 2013, Pages 241-246

  Maggio, Aurelio ^a,c   Vitrano, Angela ^b,c   Calvaruso, Giuseppina ^a,c   Barone, Rita ^a,c   Rigano, Paolo ^a,c   Mancuso, Luigi ^c,d   Cuccia, Liana ^c,e   Capra, Marcello ^c,e   Pitrolo, Lorella ^c,f   Prossomariti, Luciano ^c,g   Filosa, Aldo ^c,h   Caruso, Vincenzo ^c,i   Gerardi, Calogera ^c,j   Campisi, Saveria ^c,k   Cianciulli, Paolo ^c,l   Elefteriou, Androulla ^c,m,n   Angastiniotis, Michel ^c,m,n   Hamza, Hala ^c,o   Telfer, Paul ^c,p   Walker, John Malcolm ^c,q   Phrommintikul, Arintaya ^c,r   Chattipakorn, Nipon ^c,r   more..

^a AO Cervello   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UOC Medicina Trasfusionale   (Italy)

^d Fondazione Franco e Piera Cutino   (Italy)

^e ARNAS Civico   (Italy)

^f UOC Pediatria II   (Italy)

^g Centro Regionale per la Cura delle Microcitemie   (Italy)

^h AO Cardarelli   (Italy)

ⁱ ARNAS Garibaldi   (Italy)

^j AOS Eugenio ^*  (Italy)

^k UOS Centro Microcitemia   (Italy)

^l UOD Talassemia   (Italy)

^m Centro Microcitemia AO Perrino   (Italy)

ⁿ Thalassemia International Foundation   (Cyprus)

^o CAIRO UNIVERSITY   (Egypt)

^p ROYAL LONDON HOSPITAL   (United Kingdom)

^q ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^r Faculty of Medicine Chiang Mai University   (Thailand)

more..

Author keywords

Cardiac magnetic resonance; Chelation; Echocardiography; Left ventricular ejection fraction (LVEF); T2; Thalassemia major

Indexed keywords

ACCURACY; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART DEATH; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; REPRODUCIBILITY; SURVIVAL; THALASSEMIA MAJOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; BETA-THALASSEMIA; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; ROC CURVE; STROKE VOLUME; YOUNG ADULT;

EID: 84875505857     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2012.12.002     Document Type: Article

References (33)

1. Higgs D.R., Engel J.D., Stamatoyannopoulos G. Thalassemia. Lancet 2012, 379:373-383.
2. Borgna-Pignatti C., Bertelli S. Morbidity and life expectancy in patients with thalassemia major and intermedia. Eur. J. Clin. Med. Oncol. 2011, 3:1.
3. Telfer P. Update on survival in thalassemia major. Hemoglobin 2009, 33(Suppl. 1):S76-S80.
4. Modell B., Khan M., Darlison M. Survival in beta-thalassemia major in the UK: data from the UK Thalassemia Register. Lancet 2000, 355:2051-2052.
5. Borgna-Pignatti C., Rugolotto S., De Stefano P., Zhao H., Cappellini M.D., Del Vecchio G.C., Romeo M.A., Forni G.L., Gamberini M.R., Ghilardi R., Piga A., Cnaan A. Survival and complications in patients with thalassemia major treated with transfusion and desferrioxamine. Haematologica 2004, 89:1187-1193.
6. Ladis V., Chouliaras G., Berdoukas V., Moraitis P., Berdoussi E., Kattamis C. Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit. Eur. J. Haematol. 2010, 85:335-344.
7. Gabutti V., Piga A. Results of long-term iron-chelating therapy. Acta Haematol. 1996, 95:26-36.
8. Cunningham M.J., Macklin E.A., Neufeld E.J., Cohen A.R. Complications of beta-thalassemia major in North America. Blood 2004, 104:34-39.
9. Murphy C.J., Oudit G.Y. Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. J. Card. Fail. 2010, 16:888-900.
10. Aessopos A., Berdoukas V., Tsironi M. The heart in transfusion dependent homozygous thalassaemia today - prediction, prevention and management. Eur. J. Haematol. 2008, 80:93-106.
11. Wood J.C. Diagnosis and management of transfusion iron overload: the role of imaging. Am. J. Hematol. 2007, 82(12 Suppl.):1132-1135.
12. Anderson L.J., Holden S., Davis B., Prescott E., Charrier C.C., Bunce N.H., Firmin D.N., Wonke B., Porter J., Walker J.M., Pennell D.J. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 2001, 22:2171-2179.
13. Kirk P., Roughton M., Porter J.B., Walker J.M., Tanner M.A., Patel J., Wu D., Taylor J., Westwood M.A., Anderson L.J., Pennell D.J. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major P. Circulation 2009, 120:1961-1968.
14. Marsella M., Borgna-Pignatti C., Meloni A., Caldarelli V., Dell'Amico M.C., Spasiano A., Pitrolo L., Cracolici E., Valeri G., Positano V., Lombardi M., Pepe A. Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica 2011, 96:515-520.
15. Ademola A.A. An appraisal of the cost benefit of magnetic resonance imaging in Nigeria. Nigerian Postgrad. Med. J. 2003, 10:251-253.
16. Shahgaldi K., Gudmudson P., Manouras A., Brodin L.A., Winter R. Visually estimated ejection fraction by two dimensional and triplane echocardiography is closely correlated with quantitative ejection fraction by real-time three dimensional echocardiography. Cardiovasc. Ultrasound 2009, 25:41.
17. Blondheim D.S., Beeri R., Feinberg M., Vaturi M., Shimoni S., Fehske W., Sagie A., Rosenmann D., Lysyansky P., Deutsch L., Leitman M., Kuperstein R., Hay I., Gilon D., Friedman Z., Agmon Y., Tsadok Y., Liel-Cohen N. Reliability of visual assessment of global and segmental left ventricular function: a multicenter study by the Israeli Echocardiography Research Group. J. Am. Soc. Echocardiogr. 2010, 23:258-264.
18. Giakoumis A., Berdoukas V., Gorsis E., Aessopos A. Comparison of echocardiographic (US) volumetry with cardiac magnetic resonance (CMR) imaging in transfusion ependent thalassemia major (TM). Cardiovasc. Ultrasound 2007, 5:24.
19. Otterstad J.E., Froeland G., St John Sutton M., Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur. Heart J. 1997, 18:507-513.
20. Cogliandro T., Derchi G., Mancuso L., Pannone B., Pepe A., Pili M., Bina P., Cianciulli P., De Sanctis V., Maggio A. Guideline recommendations for heart complications in thalassemia major. J. Cardiovasc. Med. (Hagerstown) 2008, 9:515-525.
21. Schiller N.B., Shah P.M., Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards. Subcommittee on Quantitation of Two-dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989, 2:358-367.
22. Hedeker D., Gibbons R.D. Longitudinal Data Analysis 2006, Hoboken Wiley, New Jersey.
23. Kalogeropoulos A.P., Georgiopoulou V.V., Gheorghiade M., Butler J. Echocardiographic evaluation of left ventricular structure and function: new modalities and potential applications in clinical trials. J. Card. Fail. 2012, 18:159-172.
24. Collett D. Modelling Binary Data 2003, Chapman & Hall, Boca Raton.
25. Maggio A., Vitrano A., Capra M., Cuccia L., et al. Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial. Br. J. Haematol. 2009, 145:245-254.
26. Hahalis G., Alexopulos D., Kremastinos D.T., Zoumbos N.C. Heart failure in beta-thalassemia syndromes: a decade of progress. Am. J. Med. 2005, 118:957-967.
27. Gula L.J., Klein G.J., Helcamp A.S., Massel D., et al. Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am. Heart J. 2008, 156:1196-1200.
28. Davis B.A., O'Sullivan C., Jarritt P.H., Porter J.B. Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 2004, 104:263-269.
29. Tanner M.A., Galanello R., Dessi C., Smith G.C., Westwood M.A., Agus A., Pibiri M., Nair S.V., Walker J.M., Pennell D.J. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J. Cardiovasc. Mag. Res. 2008, 10:12.
30. Anderson L.J., Westwood M.A., Holden S., Davis B., Prescott E., Wonke B., Porter J.B., Walker J.M., Pennell D.J. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br. J. Haematol. 2004, 127:348-355.
31. Pennell D.J., Carpenter J.P., Roughton M., Cabantchik Z. On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure. J. Cardiovasc. Mag. Res. 2011, 13:45-53.
32. Maggio A., Vitrano A., Lucania G., Capra M., Cuccia L., et al. Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients. Am. J. Haematol. 2012, 87:732-733.
33. Lang R.M., Biering M., Devereux R.B., Flachskampf F.A., Foster E., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standard Committee and the Chamber Quantification Writing Group, developer in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 2005, 18:1440-1463.